Replies to post #206595 on Biotech Values

[DewDiligence]

EPVantage comments on Imbruvica’s would-be competitors:

http://epvantage.com/Universal/View.aspx?type=Story&id=675275&isEPVantage=yes

[DewDiligence]

ABBV/JNJ—FDA grants accelerated approval for Imbruvica in MZL—a rare form of NHL:

http://finance.yahoo.com/news/u-fda-approves-imbruvica-ibrutinib-120000631.html